While TNF‐related gene signatures have been applied in malignancies such as cervical squamous cell carcinoma and bladder cancer, their applicability to kidney renal clear cell carcinoma (KIRC) remains limited [24]. This evidence concerns the gene TNF and urinary bladder carcinoma.